These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23536964)

  • 1. Regression of ductal carcinoma in situ after treatment with acupuncture.
    Dehen R
    J Altern Complement Med; 2013 Nov; 19(11):911-5. PubMed ID: 23536964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are There Alternative Strategies for the Local Management of Ductal Carcinoma in Situ?
    Rosso KJ; Weiss A; Thompson AM
    Surg Oncol Clin N Am; 2018 Jan; 27(1):69-80. PubMed ID: 29132566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ: treatment or active surveillance?
    Kuerer HM
    Expert Rev Anticancer Ther; 2015; 15(7):777-85. PubMed ID: 25938920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.
    Fisher B; Land S; Mamounas E; Dignam J; Fisher ER; Wolmark N
    Semin Oncol; 2001 Aug; 28(4):400-18. PubMed ID: 11498833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence map of ductal carcinoma in situ management options.
    Bouskill K; Hempel S; Richardson A; Ganz PA; Baxi S; Zutshi R; Larkin J; Motala A; Miles JNV; Crandall CJ
    Menopause; 2019 Nov; 26(11):1250-1258. PubMed ID: 31567868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
    Groen EJ; Elshof LE; Visser LL; Rutgers EJT; Winter-Warnars HAO; Lips EH; Wesseling J
    Breast; 2017 Feb; 31():274-283. PubMed ID: 27671693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of ductal carcinoma in situ (DCIS).
    Virnig BA; Shamliyan T; Tuttle TM; Kane RL; Wilt TJ
    Evid Rep Technol Assess (Full Rep); 2009 Sep; (185):1-549. PubMed ID: 20629475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal carcinoma in situ: a disease entity that merits more recognition.
    Dereere E; Papadimitriou K; Tjalma W; Altintas S
    Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS).
    Cheung S; Booth ME; Kearins O; Dodwell D
    Breast; 2014 Dec; 23(6):807-11. PubMed ID: 25270228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Therapeutic Approaches to DCIS.
    Doke K; Butler S; Mitchell MP
    J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):279-291. PubMed ID: 30267199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal carcinoma in situ current trends, controversies, and review of literature.
    Hong YK; McMasters KM; Egger ME; Ajkay N
    Am J Surg; 2018 Nov; 216(5):998-1003. PubMed ID: 30244816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.
    Sagara Y; Mallory MA; Wong S; Aydogan F; DeSantis S; Barry WT; Golshan M
    JAMA Surg; 2015 Aug; 150(8):739-45. PubMed ID: 26039049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ductal carcinoma in situ].
    Skaar M; Langhans L; Mertz B; Kroman N
    Ugeskr Laeger; 2018 Sep; 180(38):. PubMed ID: 30259839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K
    Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.
    Vidali C; Caffo O; Aristei C; Bertoni F; Bonetta A; Guenzi M; Iotti C; Leonardi MC; Mussari S; Neri S; Pietta N
    Radiat Oncol; 2012 Oct; 7():177. PubMed ID: 23098066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal carcinoma in situ: biology, diagnosis, and new therapies.
    Valenzuela M; Julian TB
    Clin Breast Cancer; 2007 Aug; 7(9):676-81. PubMed ID: 17919347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort.
    Sprague BL; Vacek PM; Herschorn SD; James TA; Geller BM; Trentham-Dietz A; Stein JL; Weaver DL
    Breast Cancer Res Treat; 2019 Feb; 174(1):227-235. PubMed ID: 30448897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
    Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
    Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.